What are the symptoms and treatment options for pyelonephritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pyelonephritis Symptoms and Treatment

Pyelonephritis typically presents with fever (>38°C), chills, flank pain, nausea, vomiting, and tenderness at the costovertebral angle, with or without symptoms of lower urinary tract infection such as dysuria, frequency, and urgency. 1

Clinical Presentation

Key Symptoms

  • Systemic symptoms:
    • High fever (>38°C)
    • Chills
    • Malaise
    • Vomiting
  • Localized symptoms:
    • Flank pain
    • Costovertebral angle tenderness
    • Abdominal pain
    • Lower urinary tract symptoms (dysuria, frequency, urgency) may be present but are not required for diagnosis 1

Special Populations

  • Children: Presentation may be nonspecific, especially in neonates and young infants, with symptoms similar to sepsis 1
  • Elderly and diabetic patients: May present with atypical symptoms; up to 50% of diabetic patients may not have typical flank tenderness 1
  • Pregnant women: Require special attention due to increased risk of complications 1

Diagnosis

Laboratory Testing

  • Urinalysis: Assessment of white and red blood cells and nitrite is recommended for routine diagnosis 1
    • Leukocyte esterase and nitrite tests combined have 75-84% sensitivity and 82-98% specificity for UTI 2
  • Urine culture and antimicrobial susceptibility testing: Should be performed in all cases of pyelonephritis before starting antibiotics 1
    • Positive in approximately 90% of patients with acute pyelonephritis 2
  • Blood cultures: Reserve for patients with uncertain diagnosis, immunocompromised status, or suspected hematogenous infections 2

Imaging

  • Initial imaging: Not indicated for uncomplicated pyelonephritis in the first 72 hours 1
  • Ultrasound: Recommended to rule out urinary tract obstruction or renal stone disease in patients with:
    • History of urolithiasis
    • Renal function disturbances
    • High urine pH 1
  • Additional imaging: Consider contrast-enhanced CT scan or excretory urography if:
    • Patient remains febrile after 72 hours of treatment
    • Immediate deterioration in clinical status 1
    • Suspected complications (abscess, emphysematous pyelonephritis) 3
  • Pregnant women: Use ultrasound or MRI to avoid radiation risk to the fetus 1

Treatment

Outpatient Treatment (Mild Uncomplicated Pyelonephritis)

  • Oral antibiotics:
    • Fluoroquinolones: First choice if local resistance rates <10%
      • Ciprofloxacin: 500-750 mg twice daily for 7 days
      • Levofloxacin: 750 mg once daily for 5 days 1
    • Alternatives:
      • Trimethoprim-sulfamethoxazole: 160/800 mg twice daily for 14 days
      • Cefpodoxime: 200 mg twice daily for 10 days
      • Ceftibuten: 400 mg once daily for 10 days 1

Inpatient Treatment (Severe or Complicated Pyelonephritis)

  • Indications for hospitalization:

    • Severe illness
    • Inability to tolerate oral medication
    • Suspected complications
    • Failed outpatient treatment
    • Extremes of age 2
    • Potentially obstructive pyelonephritis (risk of rapid progression to urosepsis) 1
  • Initial IV antibiotics:

    • Fluoroquinolones:
      • Ciprofloxacin: 400 mg twice daily
      • Levofloxacin: 750 mg once daily
    • Cephalosporins:
      • Ceftriaxone: 1-2 g once daily
      • Cefotaxime: 2 g three times daily
      • Cefepime: 1-2 g twice daily
    • Other options:
      • Piperacillin/tazobactam: 2.5-4.5 g three times daily
      • Aminoglycosides (gentamicin: 5 mg/kg once daily or amikacin: 15 mg/kg once daily) with or without ampicillin 1
  • Carbapenems and novel broad-spectrum antimicrobials: Reserve for patients with multidrug-resistant organisms based on culture results 1

Duration of Treatment

  • Standard duration: 7-14 days 2
  • Short outpatient courses may be equivalent to longer therapy for clinical and microbiological success but may have higher recurrence rates within 4-6 weeks 1

Follow-up

  • Repeat urine culture 1-2 weeks after completion of antibiotic therapy 2
  • If symptoms persist or recur within 4 weeks, consider subclinical "silent" pyelonephritis requiring a 14-day course of antibiotics 4
  • If symptoms and/or bacteriuria recur with the same organism, consider a prolonged 6-week course of antibiotics 4

Complications and Special Considerations

Potential Complications

  • Renal scarring (occurs in approximately 15% of children after first episode) 1
  • Renal abscess
  • Emphysematous pyelonephritis (particularly in diabetic patients) 5
  • Sepsis
  • Chronic renal failure (long-term risk is now considered low) 1

High-Risk Populations

  • Diabetic patients: More vulnerable to complications including renal abscesses and emphysematous pyelonephritis 1
  • Pregnant women: Require screening for bacteriuria and prompt treatment to prevent complications 6
  • Children: High incidence of urinary anomalies in neonates with UTI 1
  • Immunocompromised patients: May require more aggressive treatment and monitoring 1

Treatment Failure

  • Consider resistant organisms, underlying anatomic/functional abnormalities, or immunosuppressed states 2
  • Repeat blood and urine cultures
  • Consider imaging studies
  • May require change in antibiotics or surgical intervention 2

Prevention of Recurrent UTIs

  • Counseling regarding avoidance of risk factors
  • Non-antimicrobial measures (adequate hydration, voiding after intercourse)
  • Consider antimicrobial prophylaxis for recurrent infections 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Management of pyelonephritis and upper urinary tract infections.

The Urologic clinics of North America, 1999

Research

Emphysematous pyelonephritis presenting as gastroenteritis.

American journal of therapeutics, 2007

Guideline

Uncomplicated Urinary Tract Infections Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.